RegStem is an innovative biotechnology and biopharmaceutical company repurposing and creating new drugs in the regenerative medicine fields.

Based at Paris Biotech Santé, a life science incubator in the center of Paris ( ) the company is engaged in the research, development, and licensing of innovative molecules for use in Human therapies. Its mission is to bring to the market as well as a license to pharmaceutical companies after clinical trials of new pro regenerative drugs.
innovative biotechnology, biopharmaceutical, life science
Between €1-€100K
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as RegStem? We’re happy to assist you with our Startup Sourcing service.